Thomas Payne

Title: Innovations of Thomas Payne

Introduction

Thomas Payne is an accomplished inventor based in Visp, Switzerland. He has made significant contributions to the field of biotechnology, particularly in the development of cell line platforms for the production of biologics. His innovative work has the potential to enhance therapeutic applications and improve patient outcomes.

Latest Patents

One of Thomas Payne's notable patents is titled "Universal self-regulating mammalian cell line platform for the production of biologics." This patent discloses genetic control circuits, cells, and methods that utilize a repressor polypeptide to reduce the transcription rate of an exogenous therapeutic polypeptide encoding gene in response to a change in condition. This innovation represents a significant advancement in the production of biologics, allowing for more efficient and controlled therapeutic development.

Career Highlights

Thomas Payne is currently associated with Lonza Inc., a leading global provider of integrated healthcare solutions. His work at Lonza focuses on advancing biopharmaceutical manufacturing processes and enhancing the capabilities of mammalian cell lines. With a patent portfolio that includes 1 patent, he continues to push the boundaries of biotechnology.

Collaborations

Throughout his career, Thomas has collaborated with esteemed colleagues, including Robert Young and Peter Michael O'Callaghan. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the field of biotechnology.

Conclusion

Thomas Payne's contributions to the field of biotechnology, particularly through his innovative patent, demonstrate his commitment to advancing therapeutic solutions. His work at Lonza Inc. and collaborations with other experts highlight the importance of teamwork in driving innovation.